Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy.

Binstadt BA, Geha RS, Bonilla FA.

J Allergy Clin Immunol. 2003 Apr;111(4):697-703. Review.

PMID:
12704346
2.
3.

IgG receptor polymorphisms: risk factors for disease.

van der Pol W, van de Winkel JG.

Immunogenetics. 1998 Aug;48(3):222-32. Review.

PMID:
9683667
4.

Clinical relevance of Fc gamma receptor polymorphisms.

Rascu A, Repp R, Westerdaal NA, Kalden JR, van de Winkel JG.

Ann N Y Acad Sci. 1997 Apr 5;815:282-95. Review.

PMID:
9186665
5.

Meta-analysis of the association between low-affinity Fcgamma receptor gene polymorphisms and hematologic and autoimmune disease.

Trikalinos TA, Karassa FB, Ioannidis JP.

Blood. 2001 Sep 1;98(5):1634-5. No abstract available.

6.

Fc receptors for immunoglobulin G--a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis.

Vedeler CA, Myhr KM, Nyland H.

J Neuroimmunol. 2001 Aug 30;118(2):187-93. Review.

PMID:
11498253
7.

Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.

Ronda N, Hurez V, Kazatchkine MD.

Vox Sang. 1993;64(2):65-72. Review.

PMID:
8456559
8.

IgG Fc-receptor polymorphisms in Guillain-Barré syndrome.

Vedeler CA, Raknes G, Myhr KM, Nyland H.

Neurology. 2000 Sep 12;55(5):705-7.

PMID:
10980740
9.

Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.

Ibáñez C, Montoro-Ronsano JB.

Curr Pharm Biotechnol. 2003 Aug;4(4):239-47. Review.

PMID:
14529426
10.

Immune supplementation and immune modulation with intravenous immunoglobulin.

Mazer BD, Al-Tamemi S, Yu JW, Hamid Q.

J Allergy Clin Immunol. 2005 Oct;116(4):941-4. No abstract available.

PMID:
16210080
11.

The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.

Karassa FB, Trikalinos TA, Ioannidis JP.

Biomed Pharmacother. 2004 Jun;58(5):286-91.

PMID:
15194164
12.

[Immune regulation by Fc receptors].

Takai T.

Nihon Rinsho. 2005 Apr;63 Suppl 4:420-7. Review. Japanese. No abstract available.

PMID:
15861691
13.

Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.

Lazarus AH.

J Clin Immunol. 2010 May;30 Suppl 1:S20-3. doi: 10.1007/s10875-010-9410-9. Review.

PMID:
20401687
14.

[Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].

Vermeulen M.

Ned Tijdschr Geneeskd. 1993 Sep 25;137(39):1955-8. Review. Dutch. No abstract available.

PMID:
8413702
15.

Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.

Crow AR, Lazarus AH.

J Pediatr Hematol Oncol. 2003 Dec;25 Suppl 1:S14-8. Review.

PMID:
14668633
16.

Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.

Sibéril S, Elluru S, Negi VS, Ephrem A, Misra N, Delignat S, Bayary J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.

Transfus Apher Sci. 2007 Aug;37(1):103-7. Review.

PMID:
17765663
17.

Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.

Jin F, Balthasar JP.

Hum Immunol. 2005 Apr;66(4):403-10. Review.

PMID:
15866704
18.

[Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia].

Ruiz-Argüelles GJ, Ruiz-Argüelles A, Marín-López A.

Rev Invest Clin. 1993 Mar-Apr;45(2):182-3. Spanish. No abstract available.

PMID:
8393212
19.

Immune complexes as therapy for autoimmunity.

Clynes R.

J Clin Invest. 2005 Jan;115(1):25-7.

20.

Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.

Zeidman LA, Fahey CD, Grinblatt DL, Harsanyi K.

Pediatr Neurol. 2006 Jan;34(1):60-2.

PMID:
16376282
Items per page

Supplemental Content

Support Center